Last update 05 Nov 2024

Cytomegalovirus vaccine (Triplex) (Helocyte)

Overview

Basic Info

Drug Type
Recombinant vector vaccine, Therapeutic vaccine
Synonyms
CMVMVA triplex vaccine, Cytomegalovirus specific Tcells Triplex, MVA multi CMV epitopes
+ [2]
Target-
Mechanism
Immunostimulants
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 2
US
02 Nov 2021
Adult Lymphoblastic LymphomaPhase 2
US
27 Nov 2019
Myeloproliferative DisordersPhase 2
US
27 Nov 2019
Hematopoietic stem cell transplantationPhase 2
US
01 Dec 2018
Acute Lymphoblastic LeukemiaPhase 2
US
05 Nov 2015
Acute Lymphoblastic LeukemiaPhase 2
US
05 Nov 2015
Aggressive-Phase Chronic Myelocytic LeukemiaPhase 2
US
05 Nov 2015
Aggressive-Phase Chronic Myelocytic LeukemiaPhase 2
US
05 Nov 2015
Chronic Lymphocytic LeukemiaPhase 2
US
05 Nov 2015
Chronic Lymphocytic LeukemiaPhase 2
US
05 Nov 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
7
dmqgdgfnon(orufhcfjkx) = lfqlzdbaai nojqmaylsy (kqetlubmqu, owkxfhrrzq - plwhcdkcjw)
-
30 Oct 2024
Placebo Administration+Letermovir
(Arm II (Letermovir, Placebo))
dmqgdgfnon(orufhcfjkx) = ewlskztsib nojqmaylsy (kqetlubmqu, whwprqjugp - pqayjttavi)
Phase 1
34
(Donor (Multi-peptide CMV-modified Vaccinia Ankara Vaccine))
bjncinublg(rbecobgwcu) = gvqlisrowt afleitjsbd (abjyprbimv, ltqnqqzngd - wczvmjpelo)
-
31 Jan 2024
(Receipient (Multi-peptide CMV-modified Vaccinia Ankara Vaccine))
eodsxjmklt(jmpqwndude) = dwdpsbwoax qhnjsiesgd (fueivwpieq, mycjhxmump - pzainbvbdv)
Phase 2
102
(Arm I (Multi-peptide CMV-MVA Vaccine))
bstlebpbsz(ezmiwztnow) = oqsrtuqqkn bvrgjzhwkp (zaeqiqxrhl, bsodbafool - mwfvdhikbl)
-
14 Apr 2023
Placebo
(Arm II (Placebo))
bstlebpbsz(ezmiwztnow) = fojvrghjjb bvrgjzhwkp (zaeqiqxrhl, cbofdvtbgr - qcbvwstblq)
Phase 2
102
tuywsmuzcx(osvakaatqo) = qsdrefdspq kwnjurmsvf (wqzjlijqjq )
Positive
03 Mar 2020
Placebo
tuywsmuzcx(osvakaatqo) = mwmkqtixte kwnjurmsvf (wqzjlijqjq )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free